Tsumura & Co banner

Tsumura & Co
TSE:4540

Watchlist Manager
Tsumura & Co Logo
Tsumura & Co
TSE:4540
Watchlist
Price: 4 040 JPY -2.16%
Market Cap: ¥310.1B

Net Margin

15.1%
Current
Improving
by 1.7%
vs 3-y average of 13.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
15.1%
=
Net Income
¥27.4B
/
Revenue
¥181.9B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
15.1%
=
Net Income
¥27.4B
/
Revenue
¥181.9B

Peer Comparison

Country Company Market Cap Net
Margin
JP
Tsumura & Co
TSE:4540
300.3B JPY
Loading...
US
Eli Lilly and Co
NYSE:LLY
960.1B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
579.4B USD
Loading...
CH
Roche Holding AG
SIX:ROG
284.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.1B GBP
Loading...
CH
Novartis AG
SIX:NOVN
235.3B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
295.4B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
158B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
122.2B USD
Loading...

Market Distribution

Higher than 86% of companies in Japan
Percentile
86th
Based on 6 917 companies
86th percentile
15.1%
Low
-122 700% — 2.9%
Typical Range
2.9% — 8.5%
High
8.5% — 63 031.4%
Distribution Statistics
Japan
Min -122 700%
30th Percentile 2.9%
Median 5.4%
70th Percentile 8.5%
Max 63 031.4%

Tsumura & Co
Glance View

Market Cap
310.1B JPY
Industry
Pharmaceuticals

Tsumura & Co., a venerable name in the herbal medicine industry, traces its roots back to 1893. Emerging from Japan's rich pharmacopeia tradition, the company has carved a niche by blending age-old herbal knowledge with contemporary research and quality control. This synergy allows Tsumura to thrive in the modern marketplace, offering Kampo—a traditional Japanese herbal medicine—as their primary product line. Tsumura stands out in its meticulous approach to sourcing high-quality raw materials, employing state-of-the-art technology to ensure efficacy and safety. This rigorous quality assurance not only honors the integrity of traditional formulas but also aligns with the stringent standards of modern healthcare. In its pursuit of growth, Tsumura expertly navigates the delicate balance between tradition and innovation. The company generates revenue through the sale of its Kampo products, which are widely used in clinics and hospitals across Japan, reflecting a significant integration into the mainstream healthcare system. Additionally, Tsumura's strategic collaborations with pharmaceutical companies expand its reach into international markets. Through educational initiatives, they further advocate for the understanding and acceptance of herbal medicine globally. By continually investing in research and development, Tsumura aims to bolster their product offerings, ensuring that the ancient wisdom of Kampo remains relevant in today's fast-paced, health-conscious world.

Tsumura & Co Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
15.1%
=
Net Income
¥27.4B
/
Revenue
¥181.9B
What is Tsumura & Co's current Net Margin?

The current Net Margin for Tsumura & Co is 15.1%, which is above its 3-year median of 13.3%.

How has Net Margin changed over time?

Over the last 3 years, Tsumura & Co’s Net Margin has decreased from 15.2% to 15.1%. During this period, it reached a low of 9.4% on Sep 30, 2023 and a high of 17.9% on Mar 31, 2025.

Back to Top